GENOMIC CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES

被引：0

作者：

Bernard, E. ^{[1
]}

Hasserjian, R. ^{[2
]}

Greenberg, P. ^{[3
]}

Ossa, J. Arango ^{[1
]}

Creignou, M. ^{[4
]}

Nannya, Y. ^{[5
]}

Tuechler, H. ^{[6
]}

Medina-Martinez, J. ^{[1
]}

Levine, M. ^{[1
]}

Jadersten, M. ^{[4
]}

Germing, U. ^{[7
]}

Sanz, G. ^{[8
]}

Van De Loosdrecht, A. ^{[9
]}

Kosmider, O. ^{[10
]}

Follo, M. ^{[11
]}

Thol, F. ^{[12
]}

Zamora, L. ^{[13
]}

Pinheiro, R. ^{[14
]}

Pellagatti, A. ^{[15
]}

Elias, H. ^{[1
]}

Haase, D. ^{[16
]}

Ganster, C. ^{[16
]}

Ades, L. ^{[17
]}

Tobiasson, M. ^{[4
]}

Palomo, L. ^{[18
]}

Della Porta, M. ^{[19
]}

Fenaux, P. ^{[20
]}

Belickova, M. ^{[21
]}

Savona, M. ^{[22
]}

Klimek, V. ^{[23
]}

Santos, F. ^{[24
]}

Boultwood, J. ^{[15
]}

Kotsianidis, I. ^{[25
]}

Santini, V. ^{[26
]}

Sole, F. ^{[27
]}

Platzbecker, U. ^{[28
]}

Heuser, M. ^{[12
]}

Valent, P. ^{[29
]}

Finelli, C. ^{[30
]}

Voso, M. T. ^{[31
]}

Shih, L. -Y. ^{[32
]}

Fontenay, M. ^{[33
]}

Jansen, J. ^{[9
]}

Cervera-Zamora, J. ^{[34
]}

Gattermann, N. ^{[35
]}

Ebert, B. ^{[36
]}

Bejar, R. ^{[37
]}

Malcovati, L. ^{[38
,39
]}

Cazzola, M. ^{[40
]}

Ogawa, S. ^{[41
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Computat Oncol Serv, 1275 York Ave, New York, NY 10021 USA

[2] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA

[3] Stanford Univ, Ctr Canc, Med Hematol, Stanford, CA 94305 USA

[4] Karolinska Inst, Dept Med Huddinge, Ctr Hematol & Regenerat Med, Stockholm, Sweden

[5] Univ Tokyo, Div Hematopoiet Dis Control, Tokyo, Japan

[6] Hanusch Hosp, Med Dept 3, Vienna, Austria

[7] Heinrich Heine Univ Duesseldorf, Hematol Oncol & Clin Immunol, Dusseldorf, Germany

[8] Hosp Univ La Fe, Inst Invest Sanitaria La Fe, Valencia, Spain

[9] Vrije Univ Amsterdam Med Ctr, Amsterdam Univ Med Ctr, Hematol, Amsterdam, Netherlands

[10] Inst Cochin, Paris, France

[11] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy

[12] Hannover Med Sch, Hematol Hemostasis Oncol & Stem Cell Transplantat, Hannover, Germany

[13] Hosp Badalona Germans Trias & Pujol, ICO Badalona, Josep Carreras Leukemia Res Inst, Hematol Serv, Badalona, Spain

[14] Ctr Res & Drug Dev, Canc Citogen Lab, Fortaleza, Ceara, Brazil

[15] Univ Oxford, Dept Med, Oxford, England

[16] Univ Med Gottingen, Clin Hematol & Med Oncol, Gottingen, Germany

[17] Hop St Louis, Hematol, Paris, France

[18] Hosp Univ Vall dHebron, Vall Dhebron Inst Oncol Vhio, Barcelona, Spain

[19] Humanitas Clin & Res Ctr, Unit Genom Hematol Malignances, Rozzano, MI, Italy

[20] Hop St Louis, Hematol, Paris, France

[21] Inst Hematol & Blood Transfus, Gen, Prague, Czech Republic

[22] Vanderbilt Univ, Sch Med, Div Hematol Oncol, Nashville, TN 37212 USA

[23] Syros Pharmaceut Inc, Clin Dev, Cambridge, MA USA

[24] Hosp Israelita Albert Einstein, Oncol Hematol Ctr, Sao Paulo, Brazil

[25] Gen Univ Hosp Alexandroupolis, Hematol, Alexandroupolis, Greece

[26] AOUC Univ Florence, MDS Unit, Hematol, Florence, Italy

[27] Univ Autonoma Barcelona, Myelodysplast Syndromes Res Grp, Hosp Germans Trias & Pujol, Josep Carreras Leukaemia Res Inst,ICO, Badalona, Spain

[28] Univ Leipzig, Hematol Cellular Therapy Infect Dis & Hemostasis, Leipzig, Germany

[29] Med Univ Vienna, Dept Int Med 1, Div Hematol, Hemostaseol, Vienna, Austria

[30] Osped Univ Bologna, Inst Hematol Seragnoli, Bologna, Italy

[31] Tor Vergata Univ, Dept Biomed & Prevent, Rome, Italy

[32] Chang Gung Univ, Div Hematol Oncol, Taoyuan, Taiwan

[33] Univ Paris Cite, Cochin Hosp, Hematol, Paris, France

[34] Inst Invest Sanitaria La Fe, Dept Hematol, Valencia, Spain

[35] Heinrich Heine Univ Duesseldorf, Hematol Oncol & Clin Immunol, Dusseldorf, Germany

[36] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA

[37] Univ Calif San Diego, Ctr Canc, La Jolla, CA USA

[38] Univ Pavia, Pavia, Italy

[39] IRCCS S Matteo Hosp Fdn, Dept Mol Med & Hematol Oncol, Pavia, Italy

[40] IRCCS Policlin San Matteo Fdn, Dept Hematol & Oncol, Pavia, Italy

[41] Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan

[42] Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med, Stockholm, Sweden

来源：

LEUKEMIA RESEARCH | 2023年 / 128卷

关键词：

D O I：

10.1016/j.leukres.2023.107146

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P011

引用

页数：1

共 50 条

[41] Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromes
Nazha, Aziz
Seastone, David
Radivoyevitch, Tom
Przychodzen, Bartlomiej
Carraway, Hetty E.
Patel, Bhumika J.
Carew, Jennifer
Makishima, Hideki
Sekeres, Mikkael A.
Maciejewski, Jaroslaw P.
HAEMATOLOGICA, 2015, 100 (11) : E434 - E437
[42] The International Consensus Classification of myelodysplastic syndromes and related entities
Hasserjian, Robert P.
Orazi, Attilio
Orfao, Alberto
Rozman, Maria
Wang, Sa A.
VIRCHOWS ARCHIV, 2023, 482 (01) : 39 - 51
[43] The FAB classification of the myelodysplastic syndromes: The impact of the WHO proposals
Bennett, JM
LEUKEMIA, 2000, 14 (05) : 960 - 960
[44] Update on myelodysplastic syndromes: New approaches to classification and therapy
Langston, AA
Walling, R
Winton, EF
SEMINARS IN ONCOLOGY, 2004, 31 (02) : 72 - 79
[45] The French-American-British classification of myelodysplastic syndromes
Mittelman, Moshe
HAEMATOLOGICA, 2023, 108 (10) : 2559 - 2560
[46] Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes
Germing, Ulrich
Strupp, Corinna
Kuendgen, Andrea
Isa, Shadi
Knipp, Sabine
Hildebrandt, Barbara
Giagounidis, Aristoteles
Aul, Carlo
Gattermann, Norbert
Haas, Rainer
HAEMATOLOGICA, 2006, 91 (12) : 1596 - 1604
[47] MYELODYSPLASTIC SYNDROMES: OLD AND NEW CLASSIFICATION AND PROGNOSTIC SYSTEMS
Greenberg, Peter
LEUKEMIA RESEARCH, 2014, 38 : S4 - S4
[48] Bone marrow morphology and classification systems in myelodysplastic syndromes
Aul, Carlo
GiagounidiS, Aristoteles
Germing, Ulrich
CANCER TREATMENT REVIEWS, 2007, 33 : S2 - S5
[49] Validation of the WHO proposals for the classification of unclassifiable myelodysplastic syndromes
Germing, U.
Nachtkamp, K.
Strupp, C.
Hildebrandt, B.
Haas, R.
Giagounidis, A.
Kuendgen, A.
Gattermann, N.
LEUKEMIA RESEARCH, 2009, 33 : S35 - S35
[50] PROGNOSTIC VALUE OF THE FAB CLASSIFICATION FOR MYELODYSPLASTIC SYNDROMES (MDS)
AUL, C
FISCHER, JT
HORSTKOTTE, D
SCHNEIDER, W
BLUT, 1984, 49 (03): : 246 - 246

← 1 2 3 4 5 →